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Dear Editor-in-Chief 
 
Toxoplasmosis the zoonotic disease with world-
wide distribution is life-threatening in congenital 
from and in immunocompromised patients (1). 
According to seroepidemiological studies, 18%-
85% of infection is reported from different parts 
of Iran (2, 3). Both humoral and cellular immune 
systems are involved in T. gondii infection (4). In 
addition regulation role in calcium and phospho-
rus metabolism, vitamin D is an immune-
modulator (5). On the other hand 1, 25-(OH) 2 
D can act as anti-proliferative agent in mononu-
clear cells (5) and reduce the production of IL2 
and prevention of auto-immune diseases. Vita-
min D deficiency is increasing in the world (6) 
and it is estimated 70% in Iranian people (7). 
Based on this project, from the referred patients 
to Medical Laboratory in Kashan, Iran, 70 indi-
viduals checked for vitamin D were selected. 
People taking vitamin D supplements in the last 3 
months and patients with chronic diseases were 
excluded from the study. Blood samples were 
conducted after 10 h of fasting. Vitamin D levels 
and anti-Toxoplasma IgG antibody were checked 
by commercial kit (EUROIMMUN, Germany) 
and ELISA method respectively. The mean age 
of participants was 40 yr, 72% were female and 
28% were male. Average vitamin D levels were 
9.9 ng/ml in deficient group and 67.23 ng/ml in 
normal group. Anti-T. gondii IgG antibody was 
positive in 17.14% of normal vitamin D group 
and 28.57% in vitamin D deficient group 
(P≤0/05  ( (Tables 1,2,3). Statistical analysis was 
done by SPSS software (ver. 16, Chicago, IL, 
USA) and results expressed as mean ±SD. The 
significant differences of values were analyzed 
using Student's t-test and one-way ANOVA test 
(P≤0.05). 
There was widespread high prevalence of vitamin 
D deficiency in populations (6, 7). On the other 
hand, T. gondii infection is one of the most preva-
lent infectious diseases worldwide. 
 
Table 1: Average concentration of vitamin D (ng/ml) and percent of Toxoplasma seropositivity in groups A, B 
 
No. Type Vitamin D average 
concentration(ng/ml) 
Toxoplasma seroposi-
tivity (%) 
Group A (35) Vitamin D deficient 9.9 28.57 
Group B (35) Normal vitamin D 67.23 17.14 
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Table 2: Average concentration of vitamin D (ng/ml) and percent of Toxoplasma seropositivity in age groups of 
group A 
 
Age (yr) No. Vitamin D average concentra-
tion (ng/ml) 
Toxoplasma seropositivity No. (% ) 
0-10 1 16.26 - 
11-20 3 4.6 - 
21-30 7 7.77 1(2.85) 
31-40 14 7.38 5 (14.28) 
41-50 5 13.6 3 (8.58) 
>50 6 10.35 1 (2.85) 
Total 35 9.9 10 (28.56) 
One-Way ANOVA test (P<0.05) 
 
Table 3: Average concentration of vitamin D (ng/ml) and percent of Toxoplasma seropositivity in age groups of 
group B 
 
Age (yr) No. Vitamin D average concentra-
tion (ng/ml) 
Toxoplasma seropositivity 
No.(% ) 
0-10 4 56.62 1 (2.85) 
11-20 - - - 
21-30 5 49.23 1(2.85) 
31-40 3 60.4 - 
41-50 12 55.58 3 (8.5) 
>50 11 47.11 1 (2.85) 
Total 35 67.23 6 (17.14) 
One-Way ANOVA test (P<0.05) 
 
Regarding the results of this study, the difference 
in prevalence of T. gondii infection in two groups 
of vitamin D sufficient and deficient individuals 
was noticeable and Toxoplasma infection was as-
sociated with vitamin D deficiency. More studies 
are suggested for in vivo and in vitro interpreta-
tion of vitamin D and parasitic infections. 
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